Shenzhen Neptunus Interlong Bio-Technique Company Limited (stock code: 08329) published its monthly return for the period ended 31 January 2026. The authorized share capital held steady at 426,000,000 H shares with a par value of RMB 0.1 each, totaling RMB 42.6 million. No change was recorded in the number of issued H shares, which remained at 426,000,000.

Additionally, the company’s domestic shares stood unchanged at 1,252,000,000. Public float requirements at the prescribed 25% threshold were confirmed to be met. No share options, warrants, convertibles, nor any other arrangements to issue additional shares were reported during this period.